GO:0034236 protein kinase A catalytic subunit binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0034236 defines the molecular function of binding to one or both catalytic subunits of protein kinase A (PKA), a central serine/threonine kinase.
• The PKA catalytic subunit (PRKACA, PRKACB, PRKACG) is normally inhibited by regulatory subunits; binding partners can localize, sequester, or modulate its activity.
• Isoform-specific interactions and splice variants such as Cbeta2 expand the functional repertoire of PKA catalytic subunit binding.
• PKA catalytic subunit interactions are implicated in pre-mRNA splicing, Hedgehog signaling, and host-pathogen interactions.
• Dysregulation of PKA catalytic subunit binding is linked to cancers, including biliary tract cancer and fibrolamellar hepatocellular carcinoma.
• CRISPR knockout, point mutation, knock-in, and overexpression models are essential to dissect the causal roles of PKA catalytic subunit binding partners.
Description
Protein kinase A (PKA) is a ubiquitous cAMP-dependent kinase that phosphorylates a vast array of substrates to control metabolism, gene expression, cell proliferation, and differentiation. The catalytic subunits of PKA (PRKACA, PRKACB, PRKACG) are the enzymatic engines of the holoenzyme, and their activity is tightly controlled by binding to regulatory subunits and to a diverse set of A-kinase anchoring proteins (AKAPs) and other interacting proteins. The Gene Ontology molecular function term GO:0034236, protein kinase A catalytic subunit binding, captures the specific interaction of a protein with one or both catalytic subunits of PKA. This function is critical for spatial and temporal regulation of PKA signaling, as binding partners can target the kinase to specific subcellular compartments, modulate its substrate specificity, or sequester it in an inactive state. Researchers study GO:0034236 to understand how PKA signaling is wired into cellular networks and how its dysregulation contributes to disease. For example, the PKA catalytic subunit interacts with splicing factors such as HA95 to influence pre-mRNA processing, and in Trypanosoma cruzi, the catalytic subunit binds and phosphorylates trans-sialidase superfamily members. In Hedgehog signaling, GRK2 kinases in the primary cilium initiate SMOOTHENED-PKA signaling, highlighting a specialized binding context for the PKA catalytic subunit. These diverse roles underscore the importance of identifying and characterizing proteins that bind the PKA catalytic subunit. This article provides a research-grade overview of GO:0034236, integrating the QuickGO definition with verified PubMed literature. We cover the molecular mechanism, key genes, regulatory features, disease associations, and experimental models, including CRISPR-based approaches, to support both basic and translational research.
protein kinase A catalytic subunit binding At A Glance
| GO ID | GO:0034236 |
|---|---|
| GO term | protein kinase A catalytic subunit binding |
| Ontology | molecular_function |
| Synonym | PKA catalytic subunit binding |
| Definition | Binding to one or both of the catalytic subunits of protein kinase A. |
| Major function | Mediates physical interaction with PKA catalytic subunits (PRKACA, PRKACB, PRKACG) to regulate PKA localization, activity, and substrate specificity. |
| Related genes | PRKACA, PRKACB, PRKACG, AKAPs, HA95, GRK2, and others. |
| Disease relevance | Cancer (e.g., biliary tract cancer, fibrolamellar hepatocellular carcinoma), signaling disorders. |
| Research methods | CRISPR knockout/knock-in, co-immunoprecipitation, FRET biosensors, phosphoproteomics. |
What Is GO:0034236?
GO:0034236, protein kinase A catalytic subunit binding, is a molecular function defined as binding to one or both of the catalytic subunits of protein kinase A (PKA). In other words, it describes the physical interaction between a protein and the catalytic subunit(s) of PKA, which may serve to localize, inhibit, activate, or otherwise modulate the kinase. This term does not imply that the binding protein is a substrate of PKA, although some binding partners are also phosphorylated by the catalytic subunit.
Why Is protein kinase A catalytic subunit binding Important in Cell Biology?
GO:0034236 is important because PKA catalytic subunit binding proteins are key determinants of PKA signaling specificity and intensity. By physically interacting with the catalytic subunit, these proteins can direct PKA to distinct subcellular locations, protect it from degradation, or alter its access to substrates, thereby shaping cellular responses to cAMP. Dysregulation of such interactions can lead to pathological signaling, as seen in cancers where PKA catalytic subunit mutations or fusion proteins drive constitutive activity. Understanding this function is therefore essential for decoding normal physiology and for developing targeted therapies.
• Controls spatial and temporal regulation of PKA signaling, affecting metabolism, gene expression, and cell growth.
• Binding partners can act as AKAPs to anchor PKA to specific organelles and signaling complexes.
• Influences pre-mRNA splicing through interactions with splicing factors like HA95.
• Plays a role in Hedgehog signaling via GRK2-mediated initiation of SMOOTHENED-PKA signaling in primary cilia.
• Implicated in host-pathogen interactions, e.g., Trypanosoma cruzi trans-sialidase phosphorylation.
• Dysregulation is linked to cancers, including biliary tract cancer and fibrolamellar hepatocellular carcinoma.
• Isoform-specific binding (e.g., Cbeta2) expands functional diversity in different tissues.
• Provides targets for pharmacological intervention to modulate PKA activity in disease.
• Essential for understanding cAMP compartmentalization and signal transduction.
• Enables CRISPR-based functional studies to establish causality in disease models.
Molecular Mechanism of protein kinase A catalytic subunit binding
Structural basis of PKA catalytic subunit binding
In simple terms: The PKA catalytic subunit has specific surfaces that allow other proteins to dock onto it.
The PKA catalytic subunit (e.g., PRKACA) adopts a bilobal kinase fold with a conserved catalytic core. Binding partners typically interact with surface regions outside the active site, such as the N-terminal lobe or the C-terminal tail, to avoid blocking catalysis. For example, the regulatory subunits of PKA bind to the catalytic subunit with high affinity, inhibiting activity until cAMP binds. Other proteins, such as AKAPs, can bind the catalytic subunit indirectly via regulatory subunits or directly through specialized domains. Structural studies using time-lapse crystallography have revealed dynamic changes in the catalytic subunit during Michaelis complex formation, which may influence binding partner interactions.
Isoform-specific interactions
In simple terms: Different versions of the PKA catalytic subunit can bind different partners, leading to tissue-specific functions.
Three genes encode PKA catalytic subunits: PRKACA (Calpha), PRKACB (Cbeta), and PRKACG (Cgamma). Splice variants such as Cbeta2 further diversify the protein. These isoforms differ in their N-terminal regions and tissue distribution, which can affect binding to partners. For instance, the Cbeta2 splice variant is enriched in brain and testis and may interact with distinct sets of proteins compared to Calpha. Such isoform-specific binding contributes to the functional specialization of PKA signaling in different cell types.
Binding partners and their roles
In simple terms: Many proteins bind the PKA catalytic subunit to control where and when it works.
Known binding partners include regulatory subunits (PRKAR1A, PRKAR1B, PRKAR2A, PRKAR2B), which maintain the inactive holoenzyme. AKAPs (e.g., AKAP79, AKAP150) bind regulatory subunits but can also interact with catalytic subunits indirectly. HA95 binds the catalytic subunit and is involved in pre-mRNA splicing. In Trypanosoma cruzi, the catalytic subunit interacts with trans-sialidase superfamily members, leading to their phosphorylation. GRK2 in primary cilia binds and initiates SMOOTHENED-PKA signaling. These examples illustrate the diverse functional consequences of GO:0034236.
Regulation of binding
In simple terms: Binding to the PKA catalytic subunit is controlled by cellular signals and post-translational modifications.
The interaction between PKA catalytic subunits and their partners is regulated by cAMP levels, which bind regulatory subunits and release active catalytic subunits. Phosphorylation of binding partners or the catalytic subunit itself can modulate affinity. For example, autophosphorylation of the catalytic subunit may affect interactions. Additionally, subcellular localization signals on binding partners determine where the interaction occurs, such as in the nucleus for splicing factors or at the primary cilium for GRK2. This dynamic regulation ensures precise control of PKA signaling.
Key Genes Involved in GO:0034236 protein kinase A catalytic subunit binding
The following genes encode proteins that bind the PKA catalytic subunit or are the catalytic subunits themselves, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRKACA | Encodes the Calpha catalytic subunit of PKA; primary effector of cAMP signaling. | Mutations and fusions are linked to cancers; target for CRISPR knockout and point mutation studies. |
| PRKACB | Encodes the Cbeta catalytic subunit; splice variants like Cbeta2 show tissue-specific expression. | Isoform-specific functions in brain and testis; studied via overexpression and knock-in models. |
| PRKACG | Encodes the Cgamma catalytic subunit; testis-specific expression. | Less studied; potential roles in spermatogenesis; CRISPR models can elucidate function. |
| PRKAR1A | Regulatory subunit type I alpha; binds and inhibits catalytic subunits. | Mutations cause Carney complex; binding studies inform disease mechanisms. |
| PRKAR2A | Regulatory subunit type II alpha; anchors PKA to AKAPs. | Important for PKA localization; knockout models reveal signaling defects. |
| PRKAR2B | Regulatory subunit type II beta; involved in adipose tissue metabolism. | Target for metabolic studies; CRISPR knockout in adipocytes. |
| AKAP1 | A-kinase anchoring protein 1; binds regulatory subunits to localize PKA. | Mitochondrial PKA signaling; knockout affects metabolism. |
| AKAP5 | A-kinase anchoring protein 5 (AKAP79/150); scaffolds PKA, PKC, and calcineurin. | Neuronal signaling; knockout mice show synaptic defects. |
| AKAP6 | A-kinase anchoring protein 6; anchors PKA to nuclear envelope. | Cardiac hypertrophy; overexpression models. |
| HA95 | Binds PKA catalytic subunit and regulates pre-mRNA splicing. | Splicing regulation; knockdown affects spliceosome assembly. |
| GRK2 | G protein-coupled receptor kinase 2; initiates SMOOTHENED-PKA signaling in cilia. | Hedgehog signaling; knockout disrupts development. |
| SMO | SMOOTHENED; interacts with GRK2 and PKA in Hedgehog pathway. | Cancer and development; point mutations affect PKA binding. |
| TS (trans-sialidase) | Trypanosoma cruzi trans-sialidase; phosphorylated by PKA catalytic subunit. | Host-pathogen interaction; potential drug target. |
| CFTR | Cystic fibrosis transmembrane conductance regulator; phosphorylated by PKA. | Channel regulation; binding studies inform CF therapies. |
| CREB1 | cAMP response element-binding protein; phosphorylated by PKA. | Gene expression; knockout affects memory. |
| GSK3B | Glycogen synthase kinase 3 beta; interacts with PKA signaling. | Neurodegeneration; CRISPR models for Alzheimer's. |
| PDE4D | Phosphodiesterase 4D; regulates cAMP levels and PKA activity. | Inflammation; inhibitors in clinical trials. |
| PRKACA fusion (DNAJB1-PRKACA) | Oncogenic fusion in fibrolamellar hepatocellular carcinoma. | Cancer driver; CRISPR knock-in models. |
How Is protein kinase A catalytic subunit binding Regulated?
The binding of proteins to the PKA catalytic subunit is regulated at multiple levels. cAMP binding to regulatory subunits releases active catalytic subunits, which can then interact with binding partners. Phosphorylation of the catalytic subunit or its partners can modulate binding affinity; for example, autophosphorylation of the catalytic subunit occurs during catalysis. Subcellular localization signals on binding partners direct the interaction to specific compartments, such as the nucleus or primary cilium. Additionally, expression levels of catalytic subunits and their partners are controlled transcriptionally and post-transcriptionally, influencing the stoichiometry of complexes.
protein kinase A catalytic subunit binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRKACA | Fibrolamellar hepatocellular carcinoma, biliary tract cancer | CRISPR knock-in of DNAJB1-PRKACA fusion in hepatocytes; knockout of PRKACA in cancer cell lines. |
| PRKAR1A | Carney complex | Knockout of PRKAR1A in patient-derived cells; point mutations to disrupt binding. |
| GRK2 | Holoprosencephaly, Hedgehog signaling defects | Knockout in mouse embryos; point mutations in GRK2 binding domain. |
| HA95 | Splicing-related disorders | Knockdown in HeLa cells; overexpression of binding-deficient mutants. |
| Trans-sialidase | Chagas disease | CRISPR knockout in Trypanosoma cruzi; point mutations to prevent phosphorylation. |
Cancer
Dysregulation of PKA catalytic subunit binding is implicated in several cancers. In biliary tract cancer, genomic analyses have identified mutations in PRKACA and related genes. The DNAJB1-PRKACA fusion, which retains the catalytic subunit's kinase domain, drives fibrolamellar hepatocellular carcinoma by constitutive PKA activity. Binding partners that normally restrain PKA may be lost or mutated, contributing to oncogenesis. Targeting these interactions is a therapeutic strategy.
Developmental disorders
Proper PKA catalytic subunit binding is essential for Hedgehog signaling, which controls embryonic development. GRK2 in the primary cilium initiates SMOOTHENED-PKA signaling; disruption of this binding leads to developmental defects such as holoprosencephaly. Similarly, mutations in regulatory subunits that bind catalytic subunits cause Carney complex, a multiple neoplasia syndrome.
Infectious disease
In Trypanosoma cruzi, the PKA catalytic subunit binds and phosphorylates trans-sialidase superfamily members, which are important for host cell invasion. This interaction represents a potential target for antiparasitic drugs. Understanding the binding interface could inform the design of inhibitors that block PKA-trans-sialidase interaction.
From protein kinase A catalytic subunit binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate binding partner affect PKA localization? | CRISPR knockout of the binding partner in cell lines, followed by immunofluorescence. |
| Does a point mutation in the PKA catalytic subunit disrupt binding? | CRISPR point mutation (e.g., in PRKACA) to alter interface residues, then co-immunoprecipitation. |
| Can a disease-associated fusion protein be modeled? | CRISPR knock-in of DNAJB1-PRKACA fusion in hepatocyte-like cells. |
| Does overexpression of a binding partner sequester PKA? | CRISPR overexpression (e.g., via CRISPRa) of the binding partner, then FRET biosensor analysis. |
| What is the tissue-specific role of Cbeta2 splice variant? | Knock-in of tagged Cbeta2 in mice; knockout of Cbeta2-specific exon. |
| Does GRK2 binding to PKA regulate Hedgehog signaling? | CRISPR knockout of GRK2 in primary cilia; point mutation of GRK2 binding domain. |
How to Study the protein kinase A catalytic subunit binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Physical interaction between PKA catalytic subunit and partners | Identifying novel binding proteins in cell lysates. |
| FRET biosensor | Real-time PKA activity and binding dynamics | Live-cell imaging of cAMP signaling. |
| CRISPR knockout screen | Genes required for PKA catalytic subunit binding or function | Cancer synthetic lethality screens. |
| X-ray crystallography | Three-dimensional structure of binding complexes | Designing inhibitors of PKA-partner interactions. |
| Phosphoproteomics | Substrates phosphorylated by PKA | Mapping signaling networks downstream of binding. |
| RNA-seq | Transcriptional changes upon perturbation of binding | Identifying pathways affected by PKA binding partners. |
| Proximity ligation assay (PLA) | In situ detection of protein-protein interactions | Visualizing binding in tissue sections. |
| Surface plasmon resonance (SPR) | Binding affinity and kinetics | Quantifying interactions between PKA and partners. |
Co-immunoprecipitation and mass spectrometry
Co-immunoprecipitation (co-IP) of the PKA catalytic subunit followed by mass spectrometry is a standard method to identify binding partners. This approach can reveal novel proteins that interact with PRKACA, PRKACB, or PRKACG under specific conditions. Coupling with quantitative proteomics allows comparison of binding profiles across cell types or disease states.
FRET and BRET biosensors
Genetically encoded FRET or BRET biosensors can monitor PKA activity and binding dynamics in live cells. For example, AKAR (A-kinase activity reporter) sensors detect phosphorylation by PKA, while sensors for protein-protein interactions can measure binding to the catalytic subunit in real time. These tools are valuable for studying spatial and temporal aspects of GO:0034236.
CRISPR-based genetic screens
Pooled CRISPR knockout or activation screens can identify genes that modulate PKA catalytic subunit binding or downstream signaling. For instance, a genome-wide knockout screen in a cancer cell line could reveal synthetic lethal interactions with PKA catalytic subunit mutations. Such screens are powerful for discovering new components of the pathway.
Structural biology and computational modeling
X-ray crystallography and cryo-EM provide atomic-level views of the PKA catalytic subunit bound to partners. Time-lapse crystallography has captured dynamic changes during catalysis. Computational docking and molecular dynamics simulations can predict binding interfaces and guide mutagenesis studies.
How CRISPR Can Be Used to Study GO:0034236 protein kinase A catalytic subunit binding
Knockout
CRISPR knockout of genes encoding PKA catalytic subunits or their binding partners is used to assess loss-of-function phenotypes. For example, knocking out PRKACA in cancer cell lines can reduce proliferation and alter signaling. Knockout of binding partners like HA95 can disrupt pre-mRNA splicing. These models help establish causality between binding and cellular processes.
Point Mutation
CRISPR point mutation introduces specific amino acid changes to disrupt or enhance binding interfaces. For instance, mutating residues in the PKA catalytic subunit that contact a binding partner can abolish interaction without affecting kinase activity. Such models are crucial for dissecting the functional significance of individual binding events.
Knock-in
CRISPR knock-in can create fusion proteins or tagged versions of PKA catalytic subunits. The DNAJB1-PRKACA fusion in fibrolamellar hepatocellular carcinoma has been modeled by knock-in in hepatocytes, recapitulating oncogenic signaling. Tagged knock-in (e.g., GFP-PRKACA) enables live-cell imaging and proteomic analysis of binding complexes.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can elevate levels of PKA catalytic subunits or binding partners to study gain-of-function effects. Overexpression of a binding partner may sequester PKA and inhibit signaling, while overexpression of the catalytic subunit can enhance phosphorylation of substrates. These models are useful for identifying dosage-sensitive interactions.
How EDITGENE Supports protein kinase A catalytic subunit binding Research
Researchers studying protein kinase A catalytic subunit binding-related genes often need to determine whether a candidate gene is causally involved in a specific signaling pathway or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of binding partners and catalytic subunit variants.
Contact EDITGENE today to design your custom CRISPR model for protein kinase A catalytic subunit binding research.
Frequently Asked Questions About protein kinase A catalytic subunit binding
What is protein kinase A catalytic subunit binding?
It is a molecular function (GO:0034236) defined as binding to one or both catalytic subunits of protein kinase A (PKA), which can regulate PKA localization, activity, and substrate specificity.
What genes are involved in protein kinase A catalytic subunit binding?
Key genes include PRKACA, PRKACB, PRKACG (catalytic subunits), regulatory subunits (PRKAR1A, PRKAR2A, etc.), AKAPs, HA95, GRK2, and others.
How is protein kinase A catalytic subunit binding regulated?
It is regulated by cAMP levels, phosphorylation, and subcellular localization signals on binding partners.
What diseases are associated with protein kinase A catalytic subunit binding?
Cancers such as biliary tract cancer and fibrolamellar hepatocellular carcinoma, developmental disorders like holoprosencephaly, and infectious diseases like Chagas disease.
What methods are used to study protein kinase A catalytic subunit binding?
Co-immunoprecipitation, FRET biosensors, CRISPR screens, structural biology, and phosphoproteomics.
Can CRISPR be used to study protein kinase A catalytic subunit binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect the functional roles of binding partners.
What is the role of PRKACA in disease?
PRKACA mutations and fusions, such as DNAJB1-PRKACA, drive cancers like fibrolamellar hepatocellular carcinoma and biliary tract cancer.
How does PKA catalytic subunit binding affect splicing?
Binding partners like HA95 interact with the PKA catalytic subunit to regulate pre-mRNA splicing.
What is the significance of GRK2 in PKA catalytic subunit binding?
GRK2 in primary cilia initiates SMOOTHENED-PKA signaling, a critical step in Hedgehog signaling.
What EDITGENE services are available for studying this term?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to PKA catalytic subunit binding research.
Conclusion
GO:0034236, protein kinase A catalytic subunit binding, is a fundamental molecular function that governs the specificity and regulation of PKA signaling. Through interactions with catalytic subunits, a diverse array of proteins control PKA localization, activity, and substrate access, impacting processes from splicing to Hedgehog signaling. Dysregulation of these interactions contributes to cancer, developmental disorders, and infectious diseases. CRISPR-based models are indispensable for establishing causality and for developing targeted therapies. EDITGENE provides end-to-end solutions to accelerate this research.
References
- 1. Turnham RE et al.. 2016. Protein kinase A catalytic subunit isoform PRKACA; History, function and physiology.. Gene 577(2):101-8 PMID: 26687711
- 2. Nakamura H et al.. 2015. Genomic spectra of biliary tract cancer.. Nat Genet 47(9):1003-10 PMID: 26258846
- 3. Søberg K et al.. 2018. The Molecular Basis for Specificity at the Level of the Protein Kinase a Catalytic Subunit.. Front Endocrinol (Lausanne) 9:538 PMID: 30258407
- 4. Kvissel AK et al.. 2007. Involvement of the catalytic subunit of protein kinase A and of HA95 in pre-mRNA splicing.. Exp Cell Res 313(13):2795-809 PMID: 17594903
- 5. Das A et al.. 2015. Protein Kinase A Catalytic Subunit Primed for Action: Time-Lapse Crystallography of Michaelis Complex Formation.. Structure 23(12):2331-2340 PMID: 26585512
- 6. Thullner S et al.. 2000. The protein kinase A catalytic subunit Cbeta2: molecular characterization and distribution of the splice variant.. Biochem J 351(Pt 1):123-32 PMID: 10998354
- 7. Bao Y et al.. 2010. Protein kinase A catalytic subunit interacts and phosphorylates members of trans-sialidase super-family in Trypanosoma cruzi.. Microbes Infect 12(10):716-26 PMID: 20466066
- 8. Walker MF et al.. 2024. GRK2 kinases in the primary cilium initiate SMOOTHENED-PKA signaling in the Hedgehog cascade.. PLoS Biol 22(8):e3002685 PMID: 39138140
